Resources
Resources, News & MoreFeatured Resources
Helpful resources from reputable nonprofit organizations:
➜ American Heart Association: Recurrent Pericarditis Podcast Series
➜ NORD: Rare Database- Recurrent Pericarditis
➜ Myocarditis Foundation- Pericarditis
➜ French Association for Myocarditis and Pericarditis (AFMP)
The Longitudinal Incidence of Pericarditis in 1.6 Million Patients: A 20-Year Study
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept
Pericarditis Alliance Q&A Event December 5, 2023
Pericarditis Alliance Q&A Event December 5, 2023
Recurrent Pericarditis – Nancy’s Story
MSNBC Heart Health Special
MSNBC Heart Health Special
Recurrent Pericarditis Story – Matt
← Go Back Meet Matt Matt’s story of recurrent pericarditis (RP) is one of an unexpected illness with no advance warning, no known cause and what we now know as a diagnostic odyssey that included receiving the wrong diagnosis, and delays in getting care.Matt’s story of...
MSNBC anchor opens up about health scare that led to inflammation of her heart
Pericardial Mesothelioma
Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis
Rachel Freeburg Handi-Link Interview
Pericarditis Alliance Q&A Event October 7, 2025
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis
2025 ESC Patient Guidelines for the Management of Myocarditis and Pericarditis
2025 ESC Clinical Practice Guidelines for the Management of Myocarditis and Pericarditis
Addressing Recurrent Pericarditis: A Multidisciplinary Approach to Care
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging
A New Resource for Avoiding Misdiagnosis and Undertreatment in Pericarditis
Dr. Klein on Cleveland Local News Explaining Pericarditis and the New International Consensus
The Longitudinal Incidence of Pericarditis in 1.6 Million Patients: A 20-Year Study
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept